FISHMAN ROBERT S 4
4 · 4D Molecular Therapeutics, Inc. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
FISHMAN ROBERT S
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+60,000→ 60,000 totalExercise: $8.04Exp: 2032-08-31→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.